Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Routine Oxygen Supplementation Irrelevant in Acute Stroke

By HospiMedica International staff writers
Posted on 11 Oct 2017
A new study concludes that providing routine oxygen to all stroke victims does not improve functional outcome at any stage.

Researchers at Keele University (Newcastle, United Kingdom), North Staffordshire Combined Healthcare NHS Trust (Stoke on Trent, United Kingdom), and other institutions conducted a randomized clinical trial involving 8,003 adults from 136 participating centers in the United Kingdom who suffered an acute stroke, in order to assess whether routine prophylactic low-dose oxygen therapy was more effective than control oxygen administration in reducing death and disability at 90 days.

Study participants were randomized on a 1:1:1 basis to continuous oxygen for 72 hours, nocturnal oxygen (from 21:00 to 07:00 hours) for three nights, or to a control group that received oxygen only if clinically indicated. More...
Oxygen was given via nasal tubes at 3 L/min if baseline oxygen saturation was 93% or less, and at 2 L/min if oxygen saturation was greater than 93%. The primary outcome was modified Rankin score, as assessed at 90 days by postal questionnaire, and analyzed for a common odds ratio (OR) for a change from one disability level to the next better level.

The results showed that the unadjusted OR for a better outcome was 0.97 for oxygen versus control, and 1.03 for continuous versus nocturnal oxygen; no subgroup could be identified that exhibited any benefit from oxygen supplementation. In addition, at least one serious adverse event occurred in 13% of participants in the continuous oxygen group, 11% in the nocturnal group, and 12.1% in the control group, but no significant harms were identified. The study was published on September 26, 2017, in JAMA.

“While we have shown that giving oxygen routinely to all stroke patients makes no difference, we also know that stroke patients whose oxygen levels fall below normal levels recover less well,” said lead author Professor Christine Roffe, MD, of Keele University. “Low oxygen levels are caused by underlying airway, lung and heart problems, with the most common cause being pneumonia. Therefore we now believe that it may be more important to address the underlying cause rather than just to treat the hypoxia by administering oxygen.”

Related Links:
Keele University
North Staffordshire Combined Healthcare NHS Trust


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.